Heather L. Palomino - Concepedia

Author

Heather L. Palomino

Also Known As

H Palomino, Heather L Palomino, Heather L. Palomino, Heather Palomino

Publications

257

Citations

H-Index

Concepts

All Affiliations

Heather L. Palomino is an author at Johnson & Johnson (United States) specializing in molecular pharmacology, pharmacology, and drug discovery.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	62
2	Natural Sciences	1	1	62
3	Biochemistry	1	1	62
4	Pharmacology	1	1	62
5	Drug Discovery	1	1	62

Heather L. Palomino

Publications

241

Citations

H-Index

Page 1

	Year	Citations
Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, Molecular Pharmacology	2011	72
Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues Mark D. Rosen, Hariharan Venkatesan, Hillary M. Peltier, ACS Medicinal Chemistry Letters Erythropoietin SecretionPharmacotherapyRedox BiologyOxidative StressSystems Pharmacology	2010	62
24-Hour Urine Phosphorus Excretion and Mortality and Cardiovascular Events Heather L. Palomino, Dena E. Rifkin, Cheryl A.M. Anderson, Clinical Journal of the American Society of Nephrology	2013	50
Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation‐induced anaemia in rats Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, British Journal of Pharmacology	2015	43
Characterization of a Robust Enzymatic Assay for Inhibitors of 2-Oxoglutarate-Dependent Hydroxylases Kimon C. Kanelakis, Heather L. Palomino, Lina Li, SLAS DISCOVERY	2009	14

Page 1